Intuitive Surgical, Inc. (NASDAQ: ISRG) Stock Competitors & Peer Comparison
See ISRG's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for ISRG and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ISRG | $394.51 | -1.68% | 139.4B | 41.01 | $9.62 | N/A |
| BDXA | $59.24 | -2.24% | 55.9B | 45.70 | $1.30 | +2.04% |
| BDX | $183.40 | +0.79% | 50.5B | 14.11 | $13.00 | +2.04% |
| MDLN | $35.74 | +0.45% | 30.2B | 26.19 | $1.36 | N/A |
| WST | $349.42 | +0.94% | 24.6B | 43.83 | $7.97 | +0.25% |
| HOLX | $76.01 | +0.00% | 17B | 31.54 | $2.41 | N/A |
| SOLV | $88.59 | +2.46% | 15.3B | 12.48 | $7.10 | N/A |
| COO | $76.17 | -0.56% | 14.9B | 16.70 | $4.56 | N/A |
| BAX | $26.73 | -1.18% | 13.8B | 12.85 | $2.08 | +0.75% |
| BDXB | $48.16 | +1.39% | 13.7B | 7.60 | $6.33 | +2.04% |
Stock Comparison
Becton, Dickinson and Company (NYSE: BDXA)
ISRG vs BDXA Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, BDXA has a market cap of 55.9B. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while BDXA trades at $59.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas BDXA's P/E ratio is 45.70. In terms of profitability, ISRG's ROE is +0.18%, compared to BDXA's ROE of +0.04%. Regarding short-term risk, ISRG is less volatile compared to BDXA. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check BDXA's competition here
Becton, Dickinson and Company (NYSE: BDX)
ISRG vs BDX Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, BDX has a market cap of 50.5B. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while BDX trades at $183.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas BDX's P/E ratio is 14.11. In terms of profitability, ISRG's ROE is +0.18%, compared to BDX's ROE of +0.04%. Regarding short-term risk, ISRG is more volatile compared to BDX. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check BDX's competition here
Medline Inc. (NASDAQ: MDLN)
ISRG vs MDLN Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, MDLN has a market cap of 30.2B. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while MDLN trades at $35.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas MDLN's P/E ratio is 26.19. In terms of profitability, ISRG's ROE is +0.18%, compared to MDLN's ROE of +0.05%. Regarding short-term risk, ISRG is less volatile compared to MDLN. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check MDLN's competition here
West Pharmaceutical Services, Inc. (NYSE: WST)
ISRG vs WST Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, WST has a market cap of 24.6B. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while WST trades at $349.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas WST's P/E ratio is 43.83. In terms of profitability, ISRG's ROE is +0.18%, compared to WST's ROE of +0.19%. Regarding short-term risk, ISRG is more volatile compared to WST. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check WST's competition here
Hologic, Inc. (NASDAQ: HOLX)
ISRG vs HOLX Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, HOLX has a market cap of 17B. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while HOLX trades at $76.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas HOLX's P/E ratio is 31.54. In terms of profitability, ISRG's ROE is +0.18%, compared to HOLX's ROE of +0.11%. Regarding short-term risk, ISRG is more volatile compared to HOLX. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check HOLX's competition here
Solventum Corporation (NYSE: SOLV)
ISRG vs SOLV Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, SOLV has a market cap of 15.3B. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while SOLV trades at $88.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas SOLV's P/E ratio is 12.48. In terms of profitability, ISRG's ROE is +0.18%, compared to SOLV's ROE of +0.29%. Regarding short-term risk, ISRG is less volatile compared to SOLV. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check SOLV's competition here
The Cooper Companies, Inc. (NASDAQ: COO)
ISRG vs COO Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, COO has a market cap of 14.9B. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while COO trades at $76.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas COO's P/E ratio is 16.70. In terms of profitability, ISRG's ROE is +0.18%, compared to COO's ROE of +0.03%. Regarding short-term risk, ISRG is more volatile compared to COO. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check COO's competition here
Baxter International Inc. (NYSE: BAX)
ISRG vs BAX Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, BAX has a market cap of 13.8B. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while BAX trades at $26.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas BAX's P/E ratio is 12.85. In terms of profitability, ISRG's ROE is +0.18%, compared to BAX's ROE of -0.17%. Regarding short-term risk, ISRG is more volatile compared to BAX. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check BAX's competition here
Becton, Dickinson and Company (NYSE: BDXB)
ISRG vs BDXB Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, BDXB has a market cap of 13.7B. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while BDXB trades at $48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas BDXB's P/E ratio is 7.60. In terms of profitability, ISRG's ROE is +0.18%, compared to BDXB's ROE of +0.04%. Regarding short-term risk, ISRG is less volatile compared to BDXB. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check BDXB's competition here
Repligen Corporation (NASDAQ: RGEN)
ISRG vs RGEN Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, RGEN has a market cap of 9.4B. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while RGEN trades at $166.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas RGEN's P/E ratio is 92.68. In terms of profitability, ISRG's ROE is +0.18%, compared to RGEN's ROE of +0.02%. Regarding short-term risk, ISRG is more volatile compared to RGEN. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check RGEN's competition here
Avantor, Inc. (NYSE: AVTR)
ISRG vs AVTR Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, AVTR has a market cap of 9.2B. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while AVTR trades at $13.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas AVTR's P/E ratio is 16.07. In terms of profitability, ISRG's ROE is +0.18%, compared to AVTR's ROE of -0.10%. Regarding short-term risk, ISRG is more volatile compared to AVTR. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check AVTR's competition here
AptarGroup, Inc. (NYSE: ATR)
ISRG vs ATR Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, ATR has a market cap of 8.4B. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while ATR trades at $132.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas ATR's P/E ratio is 23.09. In terms of profitability, ISRG's ROE is +0.18%, compared to ATR's ROE of +0.14%. Regarding short-term risk, ISRG is less volatile compared to ATR. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check ATR's competition here
Bausch + Lomb Corporation (NYSE: BLCO)
ISRG vs BLCO Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, BLCO has a market cap of 6.1B. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while BLCO trades at $17.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas BLCO's P/E ratio is 26.20. In terms of profitability, ISRG's ROE is +0.18%, compared to BLCO's ROE of -0.03%. Regarding short-term risk, ISRG is more volatile compared to BLCO. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check BLCO's competition here
Teleflex Incorporated (NYSE: TFX)
ISRG vs TFX Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, TFX has a market cap of 6.1B. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while TFX trades at $137.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas TFX's P/E ratio is 15.67. In terms of profitability, ISRG's ROE is +0.18%, compared to TFX's ROE of -0.32%. Regarding short-term risk, ISRG is more volatile compared to TFX. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check TFX's competition here
Stevanato Group S.p.A. (NYSE: STVN)
ISRG vs STVN Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, STVN has a market cap of 5.8B. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while STVN trades at $21.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas STVN's P/E ratio is 32.01. In terms of profitability, ISRG's ROE is +0.18%, compared to STVN's ROE of +0.09%. Regarding short-term risk, ISRG is less volatile compared to STVN. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check STVN's competition here
Merit Medical Systems, Inc. (NASDAQ: MMSI)
ISRG vs MMSI Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, MMSI has a market cap of 5.4B. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while MMSI trades at $90.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas MMSI's P/E ratio is 23.21. In terms of profitability, ISRG's ROE is +0.18%, compared to MMSI's ROE of +0.09%. Regarding short-term risk, ISRG is more volatile compared to MMSI. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check MMSI's competition here
ICU Medical, Inc. (NASDAQ: ICUI)
ISRG vs ICUI Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, ICUI has a market cap of 4.6B. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while ICUI trades at $182.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas ICUI's P/E ratio is 22.84. In terms of profitability, ISRG's ROE is +0.18%, compared to ICUI's ROE of +0.01%. Regarding short-term risk, ISRG is more volatile compared to ICUI. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check ICUI's competition here
Envista Holdings Corp (NYSE: NVST)
ISRG vs NVST Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, NVST has a market cap of 4.6B. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while NVST trades at $28.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas NVST's P/E ratio is 19.10. In terms of profitability, ISRG's ROE is +0.18%, compared to NVST's ROE of +0.04%. Regarding short-term risk, ISRG is more volatile compared to NVST. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check NVST's competition here
Pulse Biosciences, Inc. (NASDAQ: PLSE)
ISRG vs PLSE Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, PLSE has a market cap of 3.1B. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while PLSE trades at $44.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas PLSE's P/E ratio is -37.75. In terms of profitability, ISRG's ROE is +0.18%, compared to PLSE's ROE of -0.94%. Regarding short-term risk, ISRG is less volatile compared to PLSE. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check PLSE's competition here
DENTSPLY SIRONA Inc. (NASDAQ: XRAY)
ISRG vs XRAY Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, XRAY has a market cap of 2.3B. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while XRAY trades at $11.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas XRAY's P/E ratio is 8.10. In terms of profitability, ISRG's ROE is +0.18%, compared to XRAY's ROE of -0.40%. Regarding short-term risk, ISRG is less volatile compared to XRAY. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check XRAY's competition here
AtriCure, Inc. (NASDAQ: ATRC)
ISRG vs ATRC Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, ATRC has a market cap of 2.3B. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while ATRC trades at $44.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas ATRC's P/E ratio is 1375.78. In terms of profitability, ISRG's ROE is +0.18%, compared to ATRC's ROE of +0.02%. Regarding short-term risk, ISRG is less volatile compared to ATRC. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check ATRC's competition here
LeMaitre Vascular, Inc. (NASDAQ: LMAT)
ISRG vs LMAT Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, LMAT has a market cap of 1.9B. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while LMAT trades at $82.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas LMAT's P/E ratio is 30.29. In terms of profitability, ISRG's ROE is +0.18%, compared to LMAT's ROE of +0.16%. Regarding short-term risk, ISRG is less volatile compared to LMAT. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check LMAT's competition here
BioLife Solutions, Inc. (NASDAQ: BLFS)
ISRG vs BLFS Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, BLFS has a market cap of 1.7B. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while BLFS trades at $35.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas BLFS's P/E ratio is -165.93. In terms of profitability, ISRG's ROE is +0.18%, compared to BLFS's ROE of +0.13%. Regarding short-term risk, ISRG is more volatile compared to BLFS. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check BLFS's competition here
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS)
ISRG vs KMTS Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, KMTS has a market cap of 1.6B. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while KMTS trades at $28.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas KMTS's P/E ratio is -11.87. In terms of profitability, ISRG's ROE is +0.18%, compared to KMTS's ROE of -0.59%. Regarding short-term risk, ISRG is less volatile compared to KMTS. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check KMTS's competition here
Azenta, Inc. (NASDAQ: AZTA)
ISRG vs AZTA Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, AZTA has a market cap of 1.5B. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while AZTA trades at $33.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas AZTA's P/E ratio is 79.48. In terms of profitability, ISRG's ROE is +0.18%, compared to AZTA's ROE of -0.08%. Regarding short-term risk, ISRG is less volatile compared to AZTA. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check AZTA's competition here
STAAR Surgical Company (NASDAQ: STAA)
ISRG vs STAA Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, STAA has a market cap of 1.3B. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while STAA trades at $26.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas STAA's P/E ratio is 45.93. In terms of profitability, ISRG's ROE is +0.18%, compared to STAA's ROE of +0.01%. Regarding short-term risk, ISRG is less volatile compared to STAA. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check STAA's competition here
QuidelOrtho Corporation (NASDAQ: QDEL)
ISRG vs QDEL Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, QDEL has a market cap of 975.1M. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while QDEL trades at $14.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas QDEL's P/E ratio is 10.67. In terms of profitability, ISRG's ROE is +0.18%, compared to QDEL's ROE of -0.55%. Regarding short-term risk, ISRG is less volatile compared to QDEL. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check QDEL's competition here
Atrion Corporation (NASDAQ: ATRI)
ISRG vs ATRI Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, ATRI has a market cap of 809.4M. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while ATRI trades at $459.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas ATRI's P/E ratio is 64.50. In terms of profitability, ISRG's ROE is +0.18%, compared to ATRI's ROE of +0.08%. Regarding short-term risk, ISRG is more volatile compared to ATRI. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check ATRI's competition here
AngioDynamics, Inc. (NASDAQ: ANGO)
ISRG vs ANGO Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, ANGO has a market cap of 655.1M. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while ANGO trades at $15.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas ANGO's P/E ratio is -40.64. In terms of profitability, ISRG's ROE is +0.18%, compared to ANGO's ROE of -0.21%. Regarding short-term risk, ISRG is less volatile compared to ANGO. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check ANGO's competition here
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN)
ISRG vs NNNN Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, NNNN has a market cap of 381.9M. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while NNNN trades at $8.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas NNNN's P/E ratio is 125.72. In terms of profitability, ISRG's ROE is +0.18%, compared to NNNN's ROE of +0.27%. Regarding short-term risk, ISRG is less volatile compared to NNNN. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check NNNN's competition here
Sanara MedTech Inc. (NASDAQ: SMTI)
ISRG vs SMTI Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, SMTI has a market cap of 313.9M. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while SMTI trades at $34.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas SMTI's P/E ratio is -569.17. In terms of profitability, ISRG's ROE is +0.18%, compared to SMTI's ROE of -4.74%. Regarding short-term risk, ISRG is more volatile compared to SMTI. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check SMTI's competition here
OraSure Technologies, Inc. (NASDAQ: OSUR)
ISRG vs OSUR Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, OSUR has a market cap of 264.4M. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while OSUR trades at $3.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas OSUR's P/E ratio is -6.98. In terms of profitability, ISRG's ROE is +0.18%, compared to OSUR's ROE of -0.15%. Regarding short-term risk, ISRG is less volatile compared to OSUR. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check OSUR's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
ISRG vs INFU Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, INFU has a market cap of 247M. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while INFU trades at $12.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas INFU's P/E ratio is 29.85. In terms of profitability, ISRG's ROE is +0.18%, compared to INFU's ROE of +0.15%. Regarding short-term risk, ISRG is less volatile compared to INFU. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check INFU's competition here
Utah Medical Products, Inc. (NASDAQ: UTMD)
ISRG vs UTMD Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, UTMD has a market cap of 226.1M. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while UTMD trades at $71.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas UTMD's P/E ratio is 21.01. In terms of profitability, ISRG's ROE is +0.18%, compared to UTMD's ROE of +0.09%. Regarding short-term risk, ISRG is less volatile compared to UTMD. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check UTMD's competition here
Pro-Dex, Inc. (NASDAQ: PDEX)
ISRG vs PDEX Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, PDEX has a market cap of 214M. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while PDEX trades at $67.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas PDEX's P/E ratio is 23.60. In terms of profitability, ISRG's ROE is +0.18%, compared to PDEX's ROE of +0.29%. Regarding short-term risk, ISRG is less volatile compared to PDEX. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check PDEX's competition here
KORU Medical Systems, Inc. (NASDAQ: KRMD)
ISRG vs KRMD Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, KRMD has a market cap of 156.2M. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while KRMD trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas KRMD's P/E ratio is -85.00. In terms of profitability, ISRG's ROE is +0.18%, compared to KRMD's ROE of -0.11%. Regarding short-term risk, ISRG is less volatile compared to KRMD. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check KRMD's competition here
Microbot Medical Inc. (NASDAQ: MBOT)
ISRG vs MBOT Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, MBOT has a market cap of 70.6M. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while MBOT trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas MBOT's P/E ratio is -5.96. In terms of profitability, ISRG's ROE is +0.18%, compared to MBOT's ROE of -0.22%. Regarding short-term risk, ISRG is less volatile compared to MBOT. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check MBOT's competition here
Akoya Biosciences, Inc. (NASDAQ: AKYA)
ISRG vs AKYA Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, AKYA has a market cap of 64.4M. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while AKYA trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas AKYA's P/E ratio is -1.34. In terms of profitability, ISRG's ROE is +0.18%, compared to AKYA's ROE of -1.80%. Regarding short-term risk, ISRG is more volatile compared to AKYA. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check AKYA's competition here
Daxor Corporation (NASDAQ: DXR)
ISRG vs DXR Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, DXR has a market cap of 60.7M. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while DXR trades at $10.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas DXR's P/E ratio is 27.20. In terms of profitability, ISRG's ROE is +0.18%, compared to DXR's ROE of +0.22%. Regarding short-term risk, ISRG is less volatile compared to DXR. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check DXR's competition here
SkyAI, Inc. (NASDAQ: STSS)
ISRG vs STSS Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, STSS has a market cap of 53.7M. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while STSS trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas STSS's P/E ratio is -0.02. In terms of profitability, ISRG's ROE is +0.18%, compared to STSS's ROE of -1.54%. Regarding short-term risk, ISRG is less volatile compared to STSS. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check STSS's competition here
Singular Genomics Systems, Inc. (NASDAQ: OMIC)
ISRG vs OMIC Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, OMIC has a market cap of 50.8M. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while OMIC trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas OMIC's P/E ratio is -0.58. In terms of profitability, ISRG's ROE is +0.18%, compared to OMIC's ROE of -0.43%. Regarding short-term risk, ISRG is more volatile compared to OMIC. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check OMIC's competition here
GlucoTrack, Inc. (NASDAQ: IGAP)
ISRG vs IGAP Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, IGAP has a market cap of 50.2M. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while IGAP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas IGAP's P/E ratio is -10.52. In terms of profitability, ISRG's ROE is +0.18%, compared to IGAP's ROE of -0.86%. Regarding short-term risk, ISRG is less volatile compared to IGAP. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check IGAP's competition here
Nephros, Inc. (NASDAQ: NEPH)
ISRG vs NEPH Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, NEPH has a market cap of 50.2M. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while NEPH trades at $4.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas NEPH's P/E ratio is 77.08. In terms of profitability, ISRG's ROE is +0.18%, compared to NEPH's ROE of +0.16%. Regarding short-term risk, ISRG is less volatile compared to NEPH. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check NEPH's competition here
Precision Optics Corporation, Inc. (NASDAQ: POCI)
ISRG vs POCI Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, POCI has a market cap of 48M. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while POCI trades at $4.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas POCI's P/E ratio is -6.09. In terms of profitability, ISRG's ROE is +0.18%, compared to POCI's ROE of -0.37%. Regarding short-term risk, ISRG is less volatile compared to POCI. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check POCI's competition here
Milestone Scientific Inc. (AMEX: MLSS)
ISRG vs MLSS Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, MLSS has a market cap of 43.8M. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while MLSS trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas MLSS's P/E ratio is -8.25. In terms of profitability, ISRG's ROE is +0.18%, compared to MLSS's ROE of -1.49%. Regarding short-term risk, ISRG is less volatile compared to MLSS. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check MLSS's competition here
Harvard Bioscience, Inc. (NASDAQ: HBIO)
ISRG vs HBIO Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, HBIO has a market cap of 30M. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while HBIO trades at $6.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas HBIO's P/E ratio is -18.49. In terms of profitability, ISRG's ROE is +0.18%, compared to HBIO's ROE of -0.92%. Regarding short-term risk, ISRG is less volatile compared to HBIO. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check HBIO's competition here
SmileDirectClub, Inc. (NASDAQ: SDC)
ISRG vs SDC Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, SDC has a market cap of 29.1M. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while SDC trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas SDC's P/E ratio is -0.03. In terms of profitability, ISRG's ROE is +0.18%, compared to SDC's ROE of -1.96%. Regarding short-term risk, ISRG is less volatile compared to SDC. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check SDC's competition here
Jin Medical International Ltd. (NASDAQ: ZJYL)
ISRG vs ZJYL Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, ZJYL has a market cap of 26.5M. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while ZJYL trades at $3.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas ZJYL's P/E ratio is 21.13. In terms of profitability, ISRG's ROE is +0.18%, compared to ZJYL's ROE of +0.04%. Regarding short-term risk, ISRG is less volatile compared to ZJYL. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check ZJYL's competition here
Invacare Corporation (NYSE: IVC)
ISRG vs IVC Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, IVC has a market cap of 24.9M. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while IVC trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas IVC's P/E ratio is -0.79. In terms of profitability, ISRG's ROE is +0.18%, compared to IVC's ROE of -0.46%. Regarding short-term risk, ISRG is less volatile compared to IVC. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check IVC's competition here
Retractable Technologies, Inc. (AMEX: RVP)
ISRG vs RVP Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, RVP has a market cap of 20.7M. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while RVP trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas RVP's P/E ratio is -2.10. In terms of profitability, ISRG's ROE is +0.18%, compared to RVP's ROE of -0.08%. Regarding short-term risk, ISRG is less volatile compared to RVP. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check RVP's competition here
Regentis Biomaterials Ltd. (AMEX: RGNT)
ISRG vs RGNT Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, RGNT has a market cap of 13.8M. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while RGNT trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas RGNT's P/E ratio is -0.08. In terms of profitability, ISRG's ROE is +0.18%, compared to RGNT's ROE of N/A. Regarding short-term risk, ISRG is less volatile compared to RGNT. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check RGNT's competition here
Femasys Inc. (NASDAQ: FEMY)
ISRG vs FEMY Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, FEMY has a market cap of 6.9M. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while FEMY trades at $2.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas FEMY's P/E ratio is -6.33. In terms of profitability, ISRG's ROE is +0.18%, compared to FEMY's ROE of -2.58%. Regarding short-term risk, ISRG is less volatile compared to FEMY. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check FEMY's competition here
NanoString Technologies, Inc. (NASDAQ: NSTG)
ISRG vs NSTG Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, NSTG has a market cap of 5.1M. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while NSTG trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas NSTG's P/E ratio is -0.03. In terms of profitability, ISRG's ROE is +0.18%, compared to NSTG's ROE of -1.43%. Regarding short-term risk, ISRG is less volatile compared to NSTG. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check NSTG's competition here
NEXGEL, Inc. (NASDAQ: NXGL)
ISRG vs NXGL Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, NXGL has a market cap of 4.8M. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while NXGL trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas NXGL's P/E ratio is -1.45. In terms of profitability, ISRG's ROE is +0.18%, compared to NXGL's ROE of -0.70%. Regarding short-term risk, ISRG is less volatile compared to NXGL. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check NXGL's competition here
Lucyd, Inc (NASDAQ: LUCY)
ISRG vs LUCY Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, LUCY has a market cap of 4.6M. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while LUCY trades at $0.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas LUCY's P/E ratio is -0.43. In terms of profitability, ISRG's ROE is +0.18%, compared to LUCY's ROE of -0.89%. Regarding short-term risk, ISRG is less volatile compared to LUCY. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check LUCY's competition here
Predictive Oncology Inc. (NASDAQ: POAI)
ISRG vs POAI Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, POAI has a market cap of 3.6M. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while POAI trades at $4.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas POAI's P/E ratio is -0.03. In terms of profitability, ISRG's ROE is +0.18%, compared to POAI's ROE of -107.05%. Regarding short-term risk, ISRG is less volatile compared to POAI. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check POAI's competition here
GlucoTrack, Inc. (NASDAQ: GCTK)
ISRG vs GCTK Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, GCTK has a market cap of 2.8M. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while GCTK trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas GCTK's P/E ratio is -0.02. In terms of profitability, ISRG's ROE is +0.18%, compared to GCTK's ROE of -5.82%. Regarding short-term risk, ISRG is less volatile compared to GCTK. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check GCTK's competition here
Meihua International Medical Technologies Co., Ltd. (NASDAQ: MHUA)
ISRG vs MHUA Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, MHUA has a market cap of 2.4M. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while MHUA trades at $7.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas MHUA's P/E ratio is 0.25. In terms of profitability, ISRG's ROE is +0.18%, compared to MHUA's ROE of +0.07%. Regarding short-term risk, ISRG is more volatile compared to MHUA. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check MHUA's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVD)
ISRG vs GMVD Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, GMVD has a market cap of 1.8M. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while GMVD trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas GMVD's P/E ratio is -0.01. In terms of profitability, ISRG's ROE is +0.18%, compared to GMVD's ROE of +2.09%. Regarding short-term risk, ISRG is less volatile compared to GMVD. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check GMVD's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVDW)
ISRG vs GMVDW Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, GMVDW has a market cap of 1.8M. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while GMVDW trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas GMVDW's P/E ratio is N/A. In terms of profitability, ISRG's ROE is +0.18%, compared to GMVDW's ROE of +2.09%. Regarding short-term risk, ISRG is less volatile compared to GMVDW. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check GMVDW's competition here
Avinger, Inc. (NASDAQ: AVGR)
ISRG vs AVGR Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, AVGR has a market cap of 1.5M. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while AVGR trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas AVGR's P/E ratio is -0.05. In terms of profitability, ISRG's ROE is +0.18%, compared to AVGR's ROE of +17.82%. Regarding short-term risk, ISRG is less volatile compared to AVGR. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check AVGR's competition here
NEXGEL, Inc. (NASDAQ: NXGLW)
ISRG vs NXGLW Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, NXGLW has a market cap of 1.2M. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while NXGLW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas NXGLW's P/E ratio is -0.04. In terms of profitability, ISRG's ROE is +0.18%, compared to NXGLW's ROE of -0.70%. Regarding short-term risk, ISRG is less volatile compared to NXGLW. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check NXGLW's competition here
Lucyd, Inc (NASDAQ: LUCYW)
ISRG vs LUCYW Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, LUCYW has a market cap of 296.1K. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while LUCYW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas LUCYW's P/E ratio is N/A. In terms of profitability, ISRG's ROE is +0.18%, compared to LUCYW's ROE of -0.89%. Regarding short-term risk, ISRG is less volatile compared to LUCYW. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check LUCYW's competition here
Apria, Inc. (NASDAQ: APR)
ISRG vs APR Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, APR has a market cap of 0. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while APR trades at $37.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas APR's P/E ratio is 22.59. In terms of profitability, ISRG's ROE is +0.18%, compared to APR's ROE of +9.81%. Regarding short-term risk, ISRG is more volatile compared to APR. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check APR's competition here
Hill-Rom Holdings, Inc. (NYSE: HRC)
ISRG vs HRC Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, HRC has a market cap of 0. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while HRC trades at $155.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas HRC's P/E ratio is 41.92. In terms of profitability, ISRG's ROE is +0.18%, compared to HRC's ROE of +0.14%. Regarding short-term risk, ISRG is more volatile compared to HRC. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check HRC's competition here
IntriCon Corporation (NASDAQ: IIN)
ISRG vs IIN Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, IIN has a market cap of 0. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while IIN trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas IIN's P/E ratio is 226.45. In terms of profitability, ISRG's ROE is +0.18%, compared to IIN's ROE of -0.00%. Regarding short-term risk, ISRG is more volatile compared to IIN. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check IIN's competition here
Analogic Corporation (NASDAQ: ALOG)
ISRG vs ALOG Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, ALOG has a market cap of 0. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while ALOG trades at $83.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas ALOG's P/E ratio is 40.93. In terms of profitability, ISRG's ROE is +0.18%, compared to ALOG's ROE of -0.15%. Regarding short-term risk, ISRG is more volatile compared to ALOG. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check ALOG's competition here
Invuity, Inc. (NASDAQ: IVTY)
ISRG vs IVTY Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, IVTY has a market cap of 0. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while IVTY trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas IVTY's P/E ratio is -3.80. In terms of profitability, ISRG's ROE is +0.18%, compared to IVTY's ROE of -2.40%. Regarding short-term risk, ISRG is more volatile compared to IVTY. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check IVTY's competition here
Antares Pharma, Inc. (NASDAQ: ATRS)
ISRG vs ATRS Comparison August 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 139.4B. In comparison, ATRS has a market cap of 0. Regarding current trading prices, ISRG is priced at $394.51 on the NASDAQ, while ATRS trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.01, whereas ATRS's P/E ratio is 14.95. In terms of profitability, ISRG's ROE is +0.18%, compared to ATRS's ROE of +0.31%. Regarding short-term risk, ISRG is more volatile compared to ATRS. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check ATRS's competition here